tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MDCX Stock Latest News

Medicus Pharma Secures $4.5M Through Debenture Issuance
Company AnnouncementsMedicus Pharma Secures $4.5M Through Debenture Issuance
2d ago
8K
MDCX
Medicus Pharma to Present at Bio Convention and Expand Cancer Treatment Portfolio
PremiumCompany Announcements
Medicus Pharma to Present at Bio Convention and Expand Cancer Treatment Portfolio
10d ago
MDCX
Medicus Pharma Submits FDA Plan for Novel Equine Cancer Treatment
PremiumCompany Announcements
Medicus Pharma Submits FDA Plan for Novel Equine Cancer Treatment
13d ago
MDCX
Medicus Pharma Secures $7 Million for Cancer Treatment Trials
PremiumCompany Announcements
Medicus Pharma Secures $7 Million for Cancer Treatment Trials
20d ago
MDCX
Medicus Pharma Ltd. Launches $7 Million Public Offering to Advance Cancer Treatment Trials
PremiumCompany Announcements
Medicus Pharma Ltd. Launches $7 Million Public Offering to Advance Cancer Treatment Trials
23d ago
MDCX
Medicus Pharma Ltd. Gains UAE Approval for Phase 2 Basal Cell Carcinoma Study
PremiumCompany AnnouncementsMedicus Pharma Ltd. Gains UAE Approval for Phase 2 Basal Cell Carcinoma Study
1M ago
MDCX
Medicus Pharma price target raised to $27 from $14 at D. Boral Capital
Premium
The Fly
Medicus Pharma price target raised to $27 from $14 at D. Boral Capital
1M ago
MDCX
Medicus Pharma price target raised to $20 from $10 at Maxim
Premium
The Fly
Medicus Pharma price target raised to $20 from $10 at Maxim
2M ago
MDCX
Medicus Pharma to Acquire Antev Ltd. in $75 Million Deal
PremiumCompany Announcements
Medicus Pharma to Acquire Antev Ltd. in $75 Million Deal
2M ago
MDCX
Medicus Pharma Ltd’s Promising Clinical Developments and Strategic Expansion Drive Buy Rating
PremiumRatings
Medicus Pharma Ltd’s Promising Clinical Developments and Strategic Expansion Drive Buy Rating
2M ago
MDCX
Medicus Pharma Expands Phase 2 Study for Basal Cell Carcinoma Treatment
PremiumCompany Announcements
Medicus Pharma Expands Phase 2 Study for Basal Cell Carcinoma Treatment
2M ago
MDCX
Psychedelic: MindMed announces dosing in Phase 3 Emerge study
PremiumThe Fly
Psychedelic: MindMed announces dosing in Phase 3 Emerge study
2M ago
CMND
MDCX
Medicus Pharma initiated with a Buy at D. Boral Capital
PremiumThe FlyMedicus Pharma initiated with a Buy at D. Boral Capital
2M ago
MDCX
While Big Pharma Stalls, One Small-Cap Breaks Out
Premium
TipRanks Newswire
While Big Pharma Stalls, One Small-Cap Breaks Out
3M ago
MDCX
Healthcare Climbs as Tech Stumbles in 2025 Shift
Premium
TipRanks Newswire
Healthcare Climbs as Tech Stumbles in 2025 Shift
3M ago
MDCX
Medicus Pharma Secures $4.2 Million for Innovative Skin Treatment Trials
PremiumCompany Announcements
Medicus Pharma Secures $4.2 Million for Innovative Skin Treatment Trials
3M ago
MDCX
Medicus Pharma Ltd: Promising Phase 2 Results and Market Potential Drive Buy Rating
PremiumRatings
Medicus Pharma Ltd: Promising Phase 2 Results and Market Potential Drive Buy Rating
4M ago
MDCX
Medicus Pharma announces positively trending interim analysis for SKNJCT-003
PremiumThe Fly
Medicus Pharma announces positively trending interim analysis for SKNJCT-003
4M ago
MDCX
Medicus Pharma Submits Phase 2 Clinical Design for Skin Cancer Treatment in UAE
PremiumCompany Announcements
Medicus Pharma Submits Phase 2 Clinical Design for Skin Cancer Treatment in UAE
4M ago
MDCX
Medicus Pharma submits Phase 2 carcinoma clinical design in UAE
PremiumThe FlyMedicus Pharma submits Phase 2 carcinoma clinical design in UAE
4M ago
MDCX
Medicus Pharma Advances Non-Invasive Skin Cancer Treatment in UAE
Premium
Company Announcements
Medicus Pharma Advances Non-Invasive Skin Cancer Treatment in UAE
4M ago
MDCX
Medicus Pharma Ltd Poised for Growth: Buy Rating Reaffirmed Amid Promising Developments and Upcoming Catalysts
Premium
Ratings
Medicus Pharma Ltd Poised for Growth: Buy Rating Reaffirmed Amid Promising Developments and Upcoming Catalysts
4M ago
MDCX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >